Neo Kuma Ventures
VC Fund
London, United Kingdom
Neo Kuma Ventures is a VC fund in London focused on Health Care and Biotechnology. Europe's first venture capital firm to focus solely on investments into psychedelic healthcare companies. Ten investments already executed with more in the pipeline.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Neo Kuma Ventures invests in
Stages Neo Kuma Ventures invests in
Countries Neo Kuma Ventures invests in
Investment Focus
Industry
- Health Care 3 (38%)
- Biotechnology 2 (25%)
- Gaming 1 (13%)
- Medical 1 (13%)
- Computer 1 (13%)
Stage
- Seed 4 (50%)
- Pre-Seed 1 (13%)
- Series A 1 (13%)
- Convertible Note 1 (13%)
Country
- United Kingdom 4 (50%)
- United States 3 (38%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Syndi Health
|
Outcome-driven digital health support recommendation platform using machine learning and digital phenotyping - starting in mental health. | $2M / Pre-Seed / Feb 06, 2023 | |
Kanna Health
|
Kanna Health is a preclinical stage company that is developing novel therapeutics based on kanna, also known as Sceletium tortuosum. Kanna is a medicinal succulent that has been used for centuries by the San hunter-gatherers of South Africa. | $3.8M / Convertible Note / May 15, 2022 | |
Fluence
|
Fluence offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy. Our programs are designed for licensed professionals and advanced graduate students who have an opportunity to work with patient populations. Although none of our courses have specific prerequisites, a basic working knowledge ofthe mental health field and practice of psychotherapy is helpful. Our programs are interactive; we engage in discussion, demonstration, self-reflection exercises, and role plays. Some of our classes and programs are reserved for licensed clinicians, but many are open to anyone who wishes to attend. | $1.4M / Seed / Feb 15, 2022 | |
|
Fluence
|
Fluence offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy. Our programs are designed for licensed professionals and advanced graduate students who have an opportunity to work with patient populations. Although none of our courses have specific prerequisites, a basic working knowledge ofthe mental health field and practice of psychotherapy is helpful. Our programs are interactive; we engage in discussion, demonstration, self-reflection exercises, and role plays. Some of our classes and programs are reserved for licensed clinicians, but many are open to anyone who wishes to attend. | $1.6M / Seed / Nov 04, 2021 | |
wavepaths
|
Wavepaths creates accessible tools, that deepen their connection with ourselves and others, and expand their potential to have life changing experiences. | $4.5M / Seed / Nov 03, 2021 | |
Journey Clinical
|
Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care. | $3M / Seed / Sep 16, 2021 | |
Monument Therapeutics
|
Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system. | $3.6M / Seed / Jul 01, 2021 | |
TRIPP
|
TRIPP: Empowering You To Change The Way You FeelNamed the Best VR Meditation App of 2020 by Men’s Health and VR Fitness Insider, The Washington Post calls TRIPP “Meditation-meets-a-video-game-meets-a-Happy-Pill!”TRIPP is the award-winning XR platform designed to address mental and emotional well-being. Proven to drive deep engagement, TRIPPcreates advanced digital products that are based on scientific research and delivered through virtual reality, augmented reality, and mobile devices. TRIPP's platform is currently delivering wellness solutions into consumer households, Fortune 1000 companies and hospitals/clinics worldwide. | $11M / Series A / Jun 25, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Neo Kuma Ventures invest in?
Neo Kuma Ventures invests primarily in Health Care, Biotechnology and Gaming startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Neo Kuma Ventures last invest?
The most recent investment recorded for Neo Kuma Ventures closed in Feb 2023. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
